Quantinno Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
Quantinno Capital Management's ANIK Position: Q3 2026 in Review
Quantinno Capital Management increased its Anika Therapeutics (ANIK) stake by 0.05% in Q3 2026, buying an estimated $1.53K and bringing the position to 155,337 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.
Quantinno Capital Management first reported a position in ANIK in Q2 2025 and has held it in 6 quarters since. 140 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.
- Quantinno Capital Management held 155,337 shares of Anika Therapeutics worth $3.05M as of Q3 2026.
- Quantinno Capital Management bought 80 Anika Therapeutics shares in Q3 2026, an estimated $1.53K.
- Anika Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1838 holding.
- Quantinno Capital Management first reported a position in Anika Therapeutics in Q2 2025 and has held it in 6 quarters since.
- 140 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.